Founders
with Vision
to Shape the
Future of Health,
We See You.
with Vision
to Shape the
Future of Health,
We See You.
Our founders are building beyond the pre-defined edges of human health. Through the convergence of AI, technology, and biology, and the reimagining of healthcare, we’re the first call for bold entrepreneurs pushing boundaries and leading the way towards better care for all.
From life sciences to care delivery, spanning seed financing through IPO, we’re partnering with a new generation of determined, multidisciplinary entrepreneurs across the entire company‑building journey. Together we are building iconic companies that are radically transforming how we diagnose, treat, and manage disease, while building the healthcare system of tomorrow–a system of Enduring Health (™). Together, we are building the future. The Future is Health.
Themes in Bio+Health
-
Behind the Buy: Payors and Providers on AI Adoption New
Julie Yoo, Jay Rughani, Kris Tatiossian, and Olivia Webb
This episode features interviews with payor and provider leaders about what they’re seeing and how they’re thinking about AI. Guided by Julie Yoo, general partner, and Jay Rughani, investment partner at a16z Bio + Health, you'll hear from the executives about how they're utilizing AI, the KPIs they use to gauge effectiveness, and what they consider to be a good partnership.
-
Biotech Revolution with Software Engineering Daily
Sean Falconer, Vijay Pande, Kris Tatiossian, and Olivia Webb
Vijay Pande, founding general partner at a16z Bio + Health, joins the Software Engineering Daily podcast to talk about innovation in biotech and healthcare, the biotech startup landscape, the impact of AI, and much more.
-
Dark Genome Hunting with Rosana Kapeller and Marty Taylor
Vineeta Agarwala, Bryan Faust, Rosana Kapeller, Kris Tatiossian, Marty Taylor, and Olivia Webb
Rosana Kapeller, CEO of Rome Therapeutics, and Marty Taylor, physician-scientist at Harvard Medical School, join Vineeta Agarwala, general partner, and Bryan Faust, investment partner at a16z Bio + Health.
-
DNA as Data Storage with Vijay Pande
Vijay Pande, Stephanie Smith, Kris Tatiossian, and Olivia Webb
Vijay Pande, founding partner of a16z Bio + Health, dives deep with a16z Podcast host Steph Smith into the potential of DNA as a data storage mechanism.
-
The Most Interesting Healthcare Companies You’ve Never Heard Of with Julie Klapstein
Julie Klapstein, Kris Tatiossian, Olivia Webb, and Julie Yoo
Julie Klapstein, founding CEO of Availity, long-time healthcare executive, and a16z Bio + Health's newest advisory partner, joins Julie Yoo, general partner at a16z Bio + Health.
Load More
Bio Eats World is
now Raising Health
AI, science, and technology experts explore the real challenges and enormous opportunities facing entrepreneurs who are building the future of health. Raising Health dives deep into the heart of biotechnology and healthcare innovation. Join veteran company builders Vijay Pande, Julie Yoo, Vineeta Agarwala, and Jorge Conde, and co-hosts Kris Tatiossian and Olivia Webb, on this journey.
LISTEN NOW
Bio+Health Portfolio
Investing in Tome Biosciences
Jorge Conde LEARN MORE
Investing in Function Oncology
Vineeta Agarwala LEARN MORE
Investing In Marker Learning
Julie Yoo LEARN MORE
Investing In IDRx
Jorge Conde LEARN MORE
Investing in Cartography
Jorge Conde LEARN MORE
Investing in SciFi Foods
Vijay Pande LEARN MORE
Investing in Season Health
Julie Yoo LEARN MORE
Investing in Memora
Vineeta Agarwala LEARN MORE
Investing In Waymark
Vineeta Agarwala LEARN MORE
Investing in Turquoise
Julie Yoo LEARN MORE
Investing in Hippocratic AI
Julie Yoo LEARN MORE
Investing in Pomelo Care
Vineeta Agarwala LEARN MORE
FOCUS AREA
- All
- Bio
- Health
stage at initial investment
- All
- Seed
- Venture
- Growth
PORTFOLIO JOBS BOARD
-
Accolade Exit
-
AKASA
-
Amber
-
Ambience Healthcare
-
Apeel Sciences
-
Arda Therapeutics
-
Asimov
-
Bayesian Health
-
Benchling
-
BigHat Biosciences
-
BioAge Labs
-
Biodock
-
Bold
-
CAMP4 Therapeutics
-
Cardiogram Exit
-
Cartography Biosciences
-
Cedar
-
Ciitizen Exit
-
Deepcell
-
Devoted Health
-
Dyno Therapeutics
-
Earli
-
Elegen
-
EQRx Exit
-
Erasca Exit
-
Fidocure
-
Firefly Health
-
Fortuna Health
-
Freenome
-
Function Oncology
-
Gate Bio
-
Genesis Therapeutics
-
Headway
-
Hippocratic AI
-
Honor
-
IDRx
-
Inceptive
-
Incredible Health
-
Inductive Bio
-
insitro
-
Jungla Exit
-
Juniper Behavioral Health
-
Knownwell
-
Komodo Health
-
Levels Health
-
Mana Bio
-
Marker Learning
-
Marley Medical
-
Maze Therapeutics
-
Memora Health
-
Milu Health
-
Nautilus Biotechnology Exit
-
Nobell Foods
-
Octant Bio
-
Omada Health
-
Orbital Therapeutics
-
Orchestra Bio
-
Patch Biosciences Exit
-
PatientPing Exit
-
Patina
-
Pearl Health
-
Pine Medical
-
Pomelo Care
-
Propel
-
Q Bio
-
Rezo Therapeutics
-
Ribbon Health
-
Rigetti Exit
-
ROME Therapeutics
-
SCiFi Foods
-
Scribe Therapeutics
-
Season Health
-
Siduma
-
Sprinter Health
-
Thatch Health
-
Thyme Care
-
Tmunity Therapeutics Exit
-
Tome Bio
-
Tomorrow Health
-
Topography Health
-
Turquoise Health
-
Ultima Genomics
-
Valar Labs
-
Ventus Therapeutics
-
Vicinitas Therapeutics
-
Waymark
-
Zus Health
Any investments or portfolio companies mentioned, referred to, or described on this page are not representative of all investments in vehicles managed by a16z and there can be no assurance that the investments will be profitable or that other investments made in the future will have similar characteristics or results. Exits include current and former a16z portfolio companies which have been acquired as well as companies which have undergone an initial public offering or direct public offering of shares. Certain publicly traded companies on this list may still be held in Andreessen Horowitz funds. A list of investments made by funds managed by a16z is available here: https://a16z.com/investments/. Excluded from this list are investments for which the issuer has not provided permission for a16z to disclose publicly as well as unannounced investments in publicly traded digital assets. Further, the list of investments is updated monthly and as such may not reflect most recent a16z investments. Past results of Andreessen Horowitz’s investments, pooled investment vehicles, or investment strategies are not necessarily indicative of future results.
Andreessen Horowitz
x Bassett Healthcare
Catalysts. Conveners. Connective Tissue. Bringing tech-enabled innovations to patients through ecosystem partnerships.
READ MORE
Meet the Bio+Health Team
We’re former founders, operators, and entrepreneurs. We’re MDs, PhDs, scientists, and technologists. We bring the know-how and networks of five full operating teams and deep expertise from across our consumer, enterprise, and fintech practices to help founders find their edge.
We win as one team, and we win big.
See Full Team
Investing Team
Operations
Network Advisors
Want more
a16z Bio + Health?
Sign up for our bio + health newsletter to get the latest take from us on the future of biology, technology, and care delivery.
MANAGE MY SUBSCRIPTIONS By clicking the Subscribe button, you agree to the Privacy Policy.